Hot Products
| Catalog No. | Information |
| CFN90331 | Dihydrolycorine Dihydrolycorine is an inhibitors of protein synthesis in eukarytic cells, it halts protein synthesis in eukaryotic cells by inhibiting the peptide bone formation step. It protects against anoxia damage of brain in rat.Dihydrolycorine-HCL shows hypotensive effects, it can block alpha 1-adrenoceptors. |
| CFN99854 | Dihydromorin trans-Dihydromorin is an effective hypopigmenting agent in normal skin cells, hypopigmenting agents effective in melanoma system may not be effective on normal melanocytes, indicating that a non-tumor melanocyte system is more suitable for the screening of hypopigmenting agents. Dihydromorin shows strong mushroom inhibitory activity with IC50 values lower than 50 microM, more potent than (IC50 = 71.6 microM), it may be as an antibrowning agent in food systems. |
| CFN99253 | Dihydroniloticin Dihydroniloticin shows cytotoxic activity against a HT-1080 human fibrosarcoma cell line( IC50 = 8.2 microM). |
| CFN92591 | Dihydrooroxylin A Dihydrooroxylin A has significant antifeeding activity. |
| CFN93083 | Dihydropalmatine Reference standards. |
| CFN98657 | Dihydrophaseic acid Dihydrophaseic acid 3’-O-b-D-glucopyranoside (D3G) can increase the proliferation and differentiation of osteoblast cells and enhance bone formation, suggests that D3G may be a good candidate for the treatment of osteoporosis. |
| CFN95393 | Dihydrophaseic acid 4'-O-beta-D-glucopyranoside |
| CFN99829 | Dihydropinosylvin methyl ether Reference standards. |
| CFN98987 | Dihydroresveratrol Dihydroresveratrol has antiproliferative activity against human prostate cancer PC3 cell line in vitro, it can ameliorate acute pancreatitis-associated lung injury via an inhibitory modulation of pro-inflammatory response, which is associated with a suppression of the NF-κB signaling pathway. |
| CFN99021 | Dihydroresveratrol 3-O-glucoside Reference standards. |
